Newlimit

Newlimit

68
Reputation
Mid
17 open positions
Last updated Oct 27, 2026
11-50 employees
Remote0%
Hybrid0%
On-site100%
Salary shown81%
Avg. listing107d
This month5 new · 2 closed

Group Lead, Immunology

$180k–$240k/year
48
Low

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

OtherLead
See 1 similar>
3 0 0 5d ago

Scientist, mRNA Downstream Purification

$120k–$155k/year
48
Low

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

OtherMid
See 1 similar>
2 0 0 6d ago

Scientist, mRNA Analytical Development

$120k–$155k/year
48
Low

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

OtherMid
See 1 similar>
3 0 0 6d ago

Senior/Research Associate, mRNA Engineering

$75k–$100k/year
48
Low

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

Research AssociateLaboratory & Life SciencesSenior
See 2 similar>
1 0 0 6d ago

Scientist- Delivery Sciences-targeted LNPs (tLNPs)

$130k–$171k/year
39
Lowest

Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat aging by reprogramming the epigenome, a new therapeutic mechanism to restore youthful function in aged cells. We’ve built the world’s leading experimental and artificial

OtherMid
See 1 similar>
2 0 0 13d ago

Scientist, Metabolism

$130k–$165k/year
34
Lowest

Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional gen

OtherScientistMid
See 2 similar>
4 0 0 1mo ago

Senior/Research Associate, Single Cell Technology

$75k–$100k/year
34
Lowest

Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional gen

Research AssociateLaboratory & Life SciencesSenior
See 2 similar>
4 0 0 1mo ago

Senior Scientist / Scientist, In Vivo Pharmacology

$130k–$180k/year
34
Lowest

Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional gen

OtherScientistSenior
See 2 similar>
5 0 0 1mo ago

Senior Manager, Lab Operations

$140k–$170k/year
34
Lowest

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

OtherManagerSenior
See 2 similar>
5 0 0 2mo ago

Director / Senior Director, Clinical Operations

23
Lowest

Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat aging by reprogramming the epigenome, a new therapeutic mechanism to restore youthful function in aged cells. We’ve built the world’s leading experimental and artificial

OtherClinical OperationsSenior
See 2 similar>
6 0 0 3mo ago

Talent Lead

23
Lowest

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

OtherExecutive RecruiterRecruitment & Talent AcquisitionMid
See 3 similar>
4 0 0 3mo ago

Executive Assistant

23
Lowest

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat aging by reprogramming the epigenome, a new therapeutic mechanism to restore youthful function in aged cells. We’ve built the world’s leading experimental and artifici

Executive AssistantAdministration & Office SupportMid
See 2 similar>
5 0 0 3mo ago

Lead Security & Infrastructure Engineer

$160k–$220k/year
34
Lowest

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We're developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

EngineeringOtherIt & SecurityDevops EngineerLead
See 4 similar>
4 0 0 3mo ago

Principal/Senior Scientist, mRNA Engineering

$170k–$200k/year
34
Lowest

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

OtherPrincipalScientistSenior
See 3 similar>
7 0 0 6mo ago

Principal/Senior Scientist, Translational Biomarkers

$155k–$200k/year
34
Lowest

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

OtherPrincipalScientistSenior
See 3 similar>
9 0 0 6mo ago

Scientist/Senior Scientist, Immunology

$130k–$180k/year
34
Lowest

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

OtherScientistSenior
See 2 similar>
11 0 0 8mo ago

Scientist/Senior Scientist

$130k–$180k/year
34
Lowest

About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional g

OperationsOtherManagementData ScientistDataSenior
See 6 similar>
10 0 0 8mo ago